|
業務類別
|
Biotechnology |
|
業務概覽
|
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine. |
| 公司地址
| 171 Oyster Point Boulevard, Suite 500, South San Francisco, CA, USA, 94080 |
| 電話號碼
| +1 650 825-6990 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.tenayatherapeutics.com |
| 員工數量
| 97 |
| Mr. Faraz Ali, M.B.A. |
Director, Chief Executive Officer and Interim Principal Financial Officer |
美元 636.19K |
17/04/2025 |
| Mr. Tomohiro Higa |
Senior Vice President, Finance and Interim Principal Accounting Officer |
-- |
07/02/2025 |
| Dr. Whittemore Tingley, M.D.,PhD |
Chief Medical Officer |
美元 504.92K |
17/04/2025 |
|
|
| Dr. Robert Sanders Williams, M.D. |
Non-Executive Chairman of The Board |
17/04/2025 |
| Mr. Jeffrey T. Walsh, M.B.A. |
Independent Director |
17/04/2025 |
| Mr. Faraz Ali, M.B.A. |
Director, Chief Executive Officer and Interim Principal Financial Officer |
17/04/2025 |
| Ms. Amy Burroughs, M.B.A. |
Independent Director |
17/04/2025 |
| Ms. Karah Parschauer |
Independent Director |
17/04/2025 |
| Dr. June Lee, M.D. |
Independent Director |
17/04/2025 |
| Dr. Catherine Stehman-Breen, M.D. |
Independent Director |
17/04/2025 |
| Dr. Deepak Srivastava, M.D. |
Independent Director |
17/04/2025 |
|
|
|
|
